Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
/Free Sign Up
 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details
Close

Amarin Corporation PLC (AMRN)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Amarin's earnings

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create a new watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
4.240 -0.040    -0.93%
29/07 - Closed. Currency in USD ( Disclaimer )
After Hours
4.200
-0.040
-0.943%
19:49:24 - Real-time Data
Type:  Equity
Market:  United States
ISIN:  US0231112063 
CUSIP:  023111206
  • Volume: 1,875,782
  • Bid/Ask: 4.200 / 4.280
  • Day's Range: 4.205 - 4.350
Amarin 4.240 -0.040 -0.93%

AMRN Income Statement

 
Featured here, the Income Statement (earnings report) for Amarin Corporation PLC, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).
AnnualQuarterly
Collapse All
Period Ending: 2021
31/03
 2020
31/12
 2020
30/09
 2020
30/06
Total Revenue 142.17 167.25 156.5 135.32
Revenue 142.17 167.25 156.5 135.32
Other Revenue, Total - - - -
Cost of Revenue, Total 28.33 34.77 33.07 28.8
Gross Profit 113.84 132.48 123.43 106.52
Total Operating Expenses 143.5 160.09 163.44 131.16
Selling/General/Admin. Expenses, Total 105.8 116.82 120.16 92.39
Research & Development 9.38 8.51 10.2 9.97
Depreciation / Amortization - - - -
Interest Expense (Income) - Net Operating - - - -
Unusual Expense (Income) - - - -0.54
Other Operating Expenses, Total - - - -
Operating Income -1.33 7.16 -6.94 4.16
Interest Income (Expense), Net Non-Operating 0.47 0.39 0.55 0.15
Gain (Loss) on Sale of Assets - - - -
Other, Net -0.14 0.05 0.03 0.11
Net Income Before Taxes -1 7.6 -6.36 4.42
Provision for Income Taxes 0.62 2.67 0.43 -
Net Income After Taxes -1.63 4.93 -6.79 4.42
Minority Interest - - - -
Equity In Affiliates - - - -
U.S GAAP Adjustment - - - -
Net Income Before Extraordinary Items -1.63 4.93 -6.79 4.42
Total Extraordinary Items - - - -
Net Income -1.63 4.93 -6.79 4.42
Total Adjustments to Net Income - - - -
Income Available to Common Excluding Extraordinary Items -1.63 4.93 -6.79 4.42
Dilution Adjustment - - - -
Diluted Net Income -1.63 4.93 -6.79 4.42
Diluted Weighted Average Shares 394.64 390.73 389.7 399.66
Diluted EPS Excluding Extraordinary Items -0 0.01 -0.02 0.01
DPS - Common Stock Primary Issue - - - -
Diluted Normalized EPS -0 0.01 -0.02 0.01
* In Millions of USD (except for per share items)
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

AMRN Comments

Write your thoughts about Amarin Corporation PLC
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Michal Bejr
Michal Bejr Mar 30, 2021 10:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
EU approval, nice
Reply
1 1
Report
Mike Cornell
TheeAlmighty Mar 21, 2021 9:40PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Holding April 30 6.50 strike call options for EU approval!
Reply
2 0
Report
Giovanni Gambino
Giovanni Gambino Mar 20, 2021 4:43PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
over 20 Dollar end of this year
Reply
3 0
Report
Mike Cornell
TheeAlmighty Mar 08, 2021 12:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$8 this week
Reply
0 0
Report
Marc Draaisma
Marc Draaisma Mar 05, 2021 6:03AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.investing.com/news/leerink-partners-stick-to-their-buy-rating-for-amarin-corporation-plc-2436922
Reply
0 0
Report
Helmut Hay
Helmut Hay Feb 24, 2021 3:51AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What Does champ mean
Reply
0 0
Report
Michal Bejr
Michal Bejr Feb 01, 2021 9:13AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://investor.amarincorp.com/news-releases/news-release-details/amarin-receives-positive-chmp-opinion-icosapent-ethyl
Reply
0 0
Report
Michal Bejr
Michal Bejr Jan 23, 2021 2:34PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Amarin Corporation plc (NASDAQ: AMRN) announced that the Chinese Society of Cardiology has included icosapent ethyl in its updated ‘Guidelines for Primary Prevention of Cardiovascular Diseases for 2021'
Reply
3 0
Report
Rayme Marrero
Rayme Marrero Jan 21, 2021 2:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$8 By Feb. 2021
Reply
6 0
Report
Ghassan Henoud
Ghassan Henoud Jan 21, 2021 2:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice call...where next?
Reply
1 0
Report
Ghassan Henoud
Ghassan Henoud Jan 21, 2021 2:17PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
nice call...where next?
Reply
1 0
Report
Michal Bejr
Michal Bejr Jan 16, 2021 3:00AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.globenewswire.com/news-release/2021/01/07/2154744/0/en/Amarin-Provides-Preliminary-2020-Results-and-2021-Outlook.html this is going to be a pleasant summer I would say
Reply
2 0
Report
Paco Bv
Pacob Dec 23, 2020 2:49PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Yeaaah, a very slight wobble ..  great u r   ;-P
Reply
0 0
Report
Amokta amokta
Amokta amokta Dec 09, 2020 10:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Had a slight wobble, I think still likely to be heading upwards.
Reply
4 0
Report
Maxi Mare
Maxi Mare Nov 25, 2020 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
What happen with this stock? Maybe stock split?
Reply
1 0
Report
Mike Cornell
TheeAlmighty Nov 25, 2020 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Stock fell down go boom.
Reply
0 0
Report
Paco Bv
Pacob Nov 20, 2020 5:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://investor.amarincorp.com/news-releases/news-release-details/amarin-shares-topline-data-partners-pivotal-phase-3-study
Reply
0 0
Report
Paco Bv
Pacob Nov 20, 2020 5:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Mr. Xin Ni: "VASCEPA has huge commercial potential in the fast-growing Chinese market. We will work with Amarin to submit the new drug application as soon as possible to bring this cross-era innovative drug to China.”
Reply
2 0
Report
Paco Bv
Pacob Nov 20, 2020 5:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There were approximately 180.4 million hypertriglyceridemia (HTG) patients in China in 2019, representing approximately 20.2% of the adult population
Reply
0 0
Report
Max Joseph
Max Joseph Nov 06, 2020 4:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
I told you to switch with TEVA
Reply
0 0
Report
juvy ku
juvy ku Nov 06, 2020 4:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
lol $5.57
Reply
0 0
Report
Paco Bv
Pacob Nov 06, 2020 4:41PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
going to $20 again !??  I'm scared, very
Reply
0 0
Report
David Costello
David Costello Nov 06, 2020 12:33PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
what's causing stock to go down
Reply
0 0
Report
Stephen Lark
Stephen Lark Nov 05, 2020 7:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
hopefully stock goes up been beaten up for awhile now
Reply
0 0
Report
Paco Bv
Pacob Nov 05, 2020 7:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
It should go back at least above 7 because Vascepa generics did not lead to a decrease in sales, rather ... an increase? like if customers just want the most technological
Reply
2 0
Report
Paco Bv
Pacob Nov 05, 2020 7:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
... or that the demand is much higher than the supply
Reply
1 0
Report
Stephen Lark
Stephen Lark Nov 05, 2020 7:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
agreed!
Reply
0 0
Report
Paco Bv
Pacob Nov 05, 2020 6:47AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
My congratulations to Amarin for beating all earnings expectations in its third quarter
Reply
1 0
Report
Paco Bv
Pacob Oct 26, 2020 7:10AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
More important than the one below :  --> VASCEPA® (ICOSAPENT ETHYL) FOUND TO SIGNIFICANTLY REDUCE CARDIOVASCULAR EVENTS IN PATIENTS WITH COMPROMISED RENAL FUNCTION AT BASELINE IN PRESPECIFIED AND POST HOC SUBGROUP ANALYSES OF LANDMARK REDUCE-IT® STUDY
Reply
2 0
Report
Paco Bv
Pacob Oct 16, 2020 11:12AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
http://investor.amarincorp.com/news-releases/news-release-details/vascepar-icosapent-ethyl-found-significantly-reduce-ischemic
Reply
1 1
Report
Paco Bv
Pacob Oct 05, 2020 9:45AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This is meaningful:   https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html     OTOH  VASCEPA is the original and genuine oil, not just a generic from small companies  is it ok!?
Reply
1 1
Report
Paco Bv
Pacob Oct 05, 2020 9:42AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
This result is meaningful:  https://www.globenewswire.com/news-release/2020/10/05/2103391/0/en/Latest-Research-Evaluating-VASCEPA-Icosapent-Ethyl-Mechanisms-of-Action-Presented-at-European-Atherosclerosis-Society-EAS-Congress-2020.html     OTOH: VASCEPA is the original product and proce$$,  not just a generic from small companies,   is it ok!?
Reply
1 1
Report
Max Joseph
Max Joseph Sep 18, 2020 2:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Sell Amarin , buy Teva
Reply
3 1
Report
MoneyManager MoneyManager
Money2Manage4U Sep 18, 2020 2:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
REALLY Mr. Max. ? why you say this can you please explain to me ? why you basis so much in Teva even i have good experience in Teva i love Israeli people they are very smart and intelligent.
Reply
0 0
Report
Chris Jameson
Chris Jameson Sep 16, 2020 11:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
"Hedge Funds Are Dumping Amarin Corporation plc (AMRN)"
Reply
0 0
Report
Max Joseph
Max Joseph Sep 16, 2020 11:39AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
and they are buying TEVA 👍
Reply
0 0
Report
Wen Yao
Wen Yao Sep 13, 2020 9:32PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
https://www.google.com/amp/s/finance.yahoo.com/amphtml/news/amarin-amrn-vascepa-international-opportunity-001638755.html
Reply
1 1
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email